Found: 2
Select item for more details and to access through your institution.
Mechanisms of Targeting the MDM2-p53-FOXM1 Axis in Well-Differentiated Intestinal Neuroendocrine Tumors.
- Published in:
- Neuroendocrinology, 2018, v. 107, n. 1, p. 1, doi. 10.1159/000481506
- By:
- Publication type:
- Article
Inhibition of mTOR's Catalytic Site by PKI-587 Is a Promising Therapeutic Option for Gastroenteropancreatic Neuroendocrine Tumor Disease.
- Published in:
- Neuroendocrinology, 2017, v. 105, n. 1, p. 90, doi. 10.1159/000448843
- By:
- Publication type:
- Article